SEC Comment Letter for ALNYLAM PHARMACEUTICALS, INC. (ALNY) (CIK 0001178670) (ALNY) — Mar 3, 2009

ALNYLAM PHARMACEUTICALS, INC. (ALNY) (CIK 0001178670)
Date: March 3, 2009 · CIK: 0001178670 · Accession: 0000000000-09-010952

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 000-50743

Date

March 2, 2009

Author

Carlton Tartar

Form

UPLOAD

Company

ALNYLAM PHARMACEUTICALS, INC. (ALNY) (CIK 0001178670)

Letter

Via Facsimile and U.S. Mail Mail Stop 6010 March 2, 2009 Dr. John M. Maraganore Chief Executive Officer Alnylam Pharmaceuticals, Inc. 300 Third Street Cambridge, MA 02142 Re: Alnylam Pharmaceuticals, Inc. Form 10-K for the Fiscal Year Ended December 31, 2007 File No. 000-50743

Dear Dr. Maraganore: We have completed our review of your Form 10-K and have no further comments at this time. S i n c e r e l y , C a r l t o n T a r t a r B r a n c h C h i e f

Show Raw Text

Via Facsimile and U.S. Mail Mail Stop 6010
March 2, 2009
         Dr. John M. Maraganore Chief Executive Officer Alnylam Pharmaceuticals, Inc. 300 Third Street Cambridge, MA 02142
Re: Alnylam Pharmaceuticals, Inc.
 Form 10-K for the Fiscal Year Ended December 31, 2007  File No. 000-50743

Dear Dr. Maraganore:   We have completed our review of your Form 10-K and have no further comments
at this time.
       S i n c e r e l y ,
         C a r l t o n  T a r t a r         B r a n c h  C h i e f

SecProbe.io